AS3MT
Basic information
Region (hg38): 10:102869470-102901899
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the AS3MT gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 14 | 14 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 1 | |||||
Total | 0 | 0 | 14 | 0 | 1 |
Variants in AS3MT
This is a list of pathogenic ClinVar variants found in the AS3MT region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
10-102870074-G-T | Benign (Jul 05, 2018) | |||
10-102872495-G-T | not specified | Uncertain significance (Apr 23, 2024) | ||
10-102872497-A-G | not specified | Uncertain significance (Sep 29, 2022) | ||
10-102872531-G-T | not specified | Uncertain significance (May 17, 2023) | ||
10-102872588-C-G | not specified | Uncertain significance (Oct 03, 2022) | ||
10-102873124-T-C | not specified | Uncertain significance (Aug 04, 2023) | ||
10-102873130-A-G | not specified | Uncertain significance (Oct 27, 2022) | ||
10-102876981-G-A | not specified | Uncertain significance (Aug 30, 2022) | ||
10-102878390-G-A | not specified | Uncertain significance (Aug 16, 2022) | ||
10-102878429-C-A | not specified | Uncertain significance (Feb 06, 2024) | ||
10-102878924-T-C | not specified | Uncertain significance (Oct 12, 2021) | ||
10-102878941-A-G | not specified | Uncertain significance (Mar 21, 2023) | ||
10-102890608-A-G | not specified | Uncertain significance (Mar 20, 2023) | ||
10-102890620-T-C | not specified | Uncertain significance (Dec 21, 2023) | ||
10-102890629-T-C | not specified | Uncertain significance (Nov 22, 2023) | ||
10-102900606-A-G | not specified | Uncertain significance (Dec 28, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
AS3MT | protein_coding | protein_coding | ENST00000369880 | 11 | 32384 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
7.98e-11 | 0.144 | 124699 | 0 | 96 | 124795 | 0.000385 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.962 | 165 | 204 | 0.810 | 0.0000101 | 2448 |
Missense in Polyphen | 41 | 53.483 | 0.76659 | 689 | ||
Synonymous | 1.18 | 59 | 71.8 | 0.822 | 0.00000369 | 705 |
Loss of Function | 0.529 | 17 | 19.5 | 0.871 | 8.22e-7 | 258 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000853 | 0.000850 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000169 | 0.000167 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000471 | 0.000468 |
Middle Eastern | 0.000169 | 0.000167 |
South Asian | 0.000692 | 0.000654 |
Other | 0.000353 | 0.000330 |
dbNSFP
Source:
- Function
- FUNCTION: Catalyzes the transfer of a methyl group from AdoMet to trivalent arsenicals producing methylated and dimethylated arsenicals (PubMed:16407288, PubMed:25997655). It methylates arsenite to form methylarsonate, Me-AsO(3)H(2), which is reduced by methylarsonate reductase to methylarsonite, Me-As(OH)2 (PubMed:16407288, PubMed:25997655). Methylarsonite is also a substrate and it is converted into the much less toxic compound dimethylarsinate (cacodylate), Me(2)As(O)-OH (PubMed:16407288, PubMed:25997655). {ECO:0000269|PubMed:16407288, ECO:0000269|PubMed:25997655}.;
- Pathway
- Methylation;Phase II - Conjugation of compounds;Biological oxidations;Metabolism;arsenate detoxification I (glutaredoxin)
(Consensus)
Recessive Scores
- pRec
- 0.126
Intolerance Scores
- loftool
- 0.831
- rvis_EVS
- 0.55
- rvis_percentile_EVS
- 81.38
Haploinsufficiency Scores
- pHI
- 0.0906
- hipred
- N
- hipred_score
- 0.301
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0702
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- As3mt
- Phenotype
- liver/biliary system phenotype; homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- toxin metabolic process;arsonoacetate metabolic process;methylation
- Cellular component
- cytosol
- Molecular function
- arsenite methyltransferase activity;methylarsonite methyltransferase activity